Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Filter
  • 1-10 ل  73 نتائج ل ""Proto-Oncogene Proteins p21(ras)""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Targeting the HER2-ELF3-KRAS axis: a novel therapeutic strategy for KRAS G13D colorectal cancer.

  • Authors : Hwang SY; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea.; Seo Y

Subjects: Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/genetics ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/drug therapy ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/metabolism

  • Source: Molecular cancer [Mol Cancer] 2025 May 09; Vol. 24 (1), pp. 139. Date of Electronic Publication: 2025 May 09.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598

تفاصيل العنوان

×
Academic Journal

ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma.

  • Authors : Bandi DSR; Department of Hematology and Oncology, O'Neal Comprehensive Cancer Center, Heersink School of Medicine, University of Alabama, Birmingham, AL, 35233, USA.; Nagaraju GP

Subjects: Carcinoma, Pancreatic Ductal*/Carcinoma, Pancreatic Ductal*/Carcinoma, Pancreatic Ductal*/drug therapy ; Carcinoma, Pancreatic Ductal*/Carcinoma, Pancreatic Ductal*/Carcinoma, Pancreatic Ductal*/pathology ; Carcinoma, Pancreatic Ductal*/Carcinoma, Pancreatic Ductal*/Carcinoma, Pancreatic Ductal*/metabolism

  • Source: Molecular cancer [Mol Cancer] 2025 Mar 13; Vol. 24 (1), pp. 76. Date of Electronic Publication: 2025 Mar 13.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598

تفاصيل العنوان

×
Academic Journal

The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy.

  • Authors : Ma Q; RNA Oncology Group, School of Public Health, Lanzhou University, Lanzhou, 730000, People's Republic of China.; Zhang W

Subjects: Tumor Microenvironment*/Tumor Microenvironment*/Tumor Microenvironment*/genetics ; Neoplasms*/Neoplasms*/Neoplasms*/metabolism ; Neoplasms*/Neoplasms*/Neoplasms*/pathology

  • Source: Molecular cancer [Mol Cancer] 2025 Jan 13; Vol. 24 (1), pp. 14. Date of Electronic Publication: 2025 Jan 13.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598

تفاصيل العنوان

×
Academic Journal

Targeting KRAS: from metabolic regulation to cancer treatment.

  • Authors : Shi Y; Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, 100191, China.; Zheng H

Subjects: Proto-Oncogene Proteins p21(ras)*/Proto-Oncogene Proteins p21(ras)*/Proto-Oncogene Proteins p21(ras)*/genetics ; Proto-Oncogene Proteins p21(ras)*/Proto-Oncogene Proteins p21(ras)*/Proto-Oncogene Proteins p21(ras)*/antagonists & inhibitors ; Proto-Oncogene Proteins p21(ras)*/Proto-Oncogene Proteins p21(ras)*/Proto-Oncogene Proteins p21(ras)*/metabolism

  • Source: Molecular cancer [Mol Cancer] 2025 Jan 11; Vol. 24 (1), pp. 9. Date of Electronic Publication: 2025 Jan 11.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598

تفاصيل العنوان

×
Academic Journal

Intercellular TIMP-1-CD63 signaling directs the evolution of immune escape and metastasis in KRAS-mutated pancreatic cancer cells.

  • Authors : Wang CA; Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Department of Physiology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Subjects: Signal Transduction* ; Tumor Escape* ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/genetics

  • Source: Molecular cancer [Mol Cancer] 2025 Jan 18; Vol. 24 (1), pp. 25. Date of Electronic Publication: 2025 Jan 18.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598

تفاصيل العنوان

×
Academic Journal

Targeting KRAS mutant cancers: from druggable therapy to drug resistance.

  • Authors : Zhu C; The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, 310022, China.; School of Molecular Medicine, Hangzhou Institute for Advanced Study, UCAS, Hangzhou, 310024, China.

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/drug therapy ; Neoplasms*/Neoplasms*/Neoplasms*/genetics ; Proto-Oncogene Proteins p21(ras)*/Proto-Oncogene Proteins p21(ras)*/Proto-Oncogene Proteins p21(ras)*/genetics

  • Source: Molecular cancer [Mol Cancer] 2022 Aug 04; Vol. 21 (1), pp. 159. Date of Electronic Publication: 2022 Aug 04.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598

تفاصيل العنوان

×
Academic Journal

Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer.

  • Authors : Zhu G; Department of Abdominal Oncology, Cancer Center and Laboratory of Molecular Targeted Therapy in Oncology, West China Hospital, Sichuan University, No.37 guoxue lane, Chengdu, 610041, Sichuan Province, China.; Pei L

Subjects: Biomarkers, Tumor* ; Oncogenes*; Colorectal Neoplasms/Colorectal Neoplasms/Colorectal Neoplasms/*diagnosis

  • Source: Molecular cancer [Mol Cancer] 2021 Nov 06; Vol. 20 (1), pp. 143. Date of Electronic Publication: 2021 Nov 06.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598

تفاصيل العنوان

×
Academic Journal

Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy.

  • Authors : Xu K; Division of Cancer Biology, Department of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, GA, 30322, USA.; Park D

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Autophagy/Autophagy/Autophagy/*genetics ; Benzoates/Benzoates/Benzoates/*pharmacology

  • Source: Molecular cancer [Mol Cancer] 2019 Apr 10; Vol. 18 (1), pp. 85. Date of Electronic Publication: 2019 Apr 10.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598

تفاصيل العنوان

×
Academic Journal

Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation.

  • Authors : Puyalto A; Department of Medical Oncology, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Program in Solid Tumors, Cancer Division, Cima Universidad de Navarra, CCUN, Av. Pio XII, 55, 31008, Pamplona, Spain.

Subjects: Adenocarcinoma of Lung*/Adenocarcinoma of Lung*/Adenocarcinoma of Lung*/drug therapy ; Adenocarcinoma of Lung*/Adenocarcinoma of Lung*/Adenocarcinoma of Lung*/genetics ; Adenocarcinoma of Lung*/Adenocarcinoma of Lung*/Adenocarcinoma of Lung*/pathology

  • Source: Molecular cancer [Mol Cancer] 2024 Apr 20; Vol. 23 (1), pp. 78. Date of Electronic Publication: 2024 Apr 20.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598

تفاصيل العنوان

×
Academic Journal

The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer.

  • Authors : Entrialgo-Cadierno R; Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, 31008, Pamplona, Spain.; Cueto-Ureña C

Subjects: Carcinoma, Pancreatic Ductal*/Carcinoma, Pancreatic Ductal*/Carcinoma, Pancreatic Ductal*/pathology ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/pathology ; Membrane Transport Proteins*/Membrane Transport Proteins*/Membrane Transport Proteins*/genetics

  • Source: Molecular cancer [Mol Cancer] 2023 May 20; Vol. 22 (1), pp. 86. Date of Electronic Publication: 2023 May 20.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598

تفاصيل العنوان

×
  • 1-10 ل  73 نتائج ل ""Proto-Oncogene Proteins p21(ras)""